PIA
SCLN

Piedmont Investment Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Piedmont Investment Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,368
Closed -$127K – 824
2017
Q3 		$127K Buy
11,368
+183
+2% +$2.02K ﹤0.01% 753
2017
Q2 		$123K Buy
+11,185
New +$112K ﹤0.01% 737

Piedmont Investment Advisors's SCLN Position: Q4 2017 in Review

Piedmont Investment Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 11,368 shares — an estimated $127K sold.

Piedmont Investment Advisors first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $127K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Piedmont Investment Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Piedmont Investment Advisors sold 11,368 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $127K.
  • Piedmont Investment Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • Piedmont Investment Advisors's Sciclone Pharmaceuticals Inc position peaked at $127K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Piedmont Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.